Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Du 21220
2. Du-21220
3. Du21220
4. Hydrochloride, Ritodrine
5. Pre Par
6. Pre-par
7. Prepar
8. Ritodrine
9. Yutopar
1. 23239-51-2
2. Ritodrine Hcl
3. Mls002153782
4. Ritodrinium
5. Nsc 291565
6. Smr001233166
7. Prestwick_763
8. Yutopar (tn)
9. Mfcd01657514
10. Ritodrin-hydrochloride
11. Ncgc00016773-01
12. Cas-23239-51-2
13. Dsstox_cid_25438
14. Dsstox_rid_80879
15. Dsstox_gsid_45438
16. Schembl122631
17. Ritodrine Hydrochloride- Bio-x
18. Chembl1201160
19. Dtxsid8045438
20. Chebi:32102
21. Hms1569e19
22. Tox21_110603
23. Ritodrine Hydrochloride (jp17/usp)
24. Akos025117464
25. Ac-3536
26. Ccg-220349
27. As-12194
28. Br164351
29. D01263
30. T72119
31. 239r512
32. J-015046
33. Ritodrine Hydrochloride, British Pharmacopoeia (bp) Reference Standard
34. Ritodrine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
35. 4-(2-(((1r,2s)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl)amino)ethyl)phenol Hydrochloride
36. 4-(2-((1r,2s)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-ylamino)ethyl)phenol Hydrochloride
37. 4-[2-[[(1r,2s)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol;hydrochloride
38. Ritodrine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Molecular Weight | 323.8 g/mol |
---|---|
Molecular Formula | C17H22ClNO3 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Exact Mass | 323.1288213 g/mol |
Monoisotopic Mass | 323.1288213 g/mol |
Topological Polar Surface Area | 72.7 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 284 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Tocolytic Agents
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
38
PharmaCompass offers a list of Ritodrine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ritodrine Hydrochloride manufacturer or Ritodrine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ritodrine Hydrochloride manufacturer or Ritodrine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Ritodrine Hydrochloride API Price utilized in the formulation of products. Ritodrine Hydrochloride API Price is not always fixed or binding as the Ritodrine Hydrochloride Price is obtained through a variety of data sources. The Ritodrine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Utopar manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Utopar, including repackagers and relabelers. The FDA regulates Utopar manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Utopar API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Utopar manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Utopar supplier is an individual or a company that provides Utopar active pharmaceutical ingredient (API) or Utopar finished formulations upon request. The Utopar suppliers may include Utopar API manufacturers, exporters, distributors and traders.
click here to find a list of Utopar suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Utopar DMF (Drug Master File) is a document detailing the whole manufacturing process of Utopar active pharmaceutical ingredient (API) in detail. Different forms of Utopar DMFs exist exist since differing nations have different regulations, such as Utopar USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Utopar DMF submitted to regulatory agencies in the US is known as a USDMF. Utopar USDMF includes data on Utopar's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Utopar USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Utopar suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Utopar Drug Master File in Japan (Utopar JDMF) empowers Utopar API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Utopar JDMF during the approval evaluation for pharmaceutical products. At the time of Utopar JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Utopar suppliers with JDMF on PharmaCompass.
Utopar Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Utopar GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Utopar GMP manufacturer or Utopar GMP API supplier for your needs.
A Utopar CoA (Certificate of Analysis) is a formal document that attests to Utopar's compliance with Utopar specifications and serves as a tool for batch-level quality control.
Utopar CoA mostly includes findings from lab analyses of a specific batch. For each Utopar CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Utopar may be tested according to a variety of international standards, such as European Pharmacopoeia (Utopar EP), Utopar JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Utopar USP).